STOCKHOLDERS’ EQUITY (Tables)

3 Months Ended

Sep. 30, 2023

Equity [Abstract]

SCHEDULE OF SHARE BASED COMPENSATION

	For the Three Months Ended September 30, 2023
Expected volatility		166% - 197	%
Expected term		6.4 years
Risk-Free interest rate		3.5% - 4.1	%
Weighted-average fair value per share of grants	$	1.41
Expected dividend yield		0	%

SCHEDULE OF SHARE BASED COMPENSATION STOCK OPTIONS

	Options Outstanding as of September 30, 2023
	Outstanding Stock Options			Weighted Average Exercise Price		Weighted Average Remaining Contractual Life (Years)		Aggregate Intrinsic Value
Outstanding as of July 1, 2023		270,000		$	1.61
Granted		240,881		$	1.18
Exercised		-		$	-
Forfeited		(20,000	)	$	1.64
Outstanding and expected to vest as of September 30, 2023		490,881		$	1.40		9.6	$	-
Exercisable as of September 30, 2023		-		$	-			$	-

SCHEDULE OF SHARE BASED COMPENSATION RESTRICTED STOCK OUTSTANDING

	Restricted Stock Outstanding as of September 30, 2023
	Number of Shares			Weighted Average Grant Date Fair Value
Nonvested as of July 1, 2023		288,733		$	1.36
Granted		447,543		$	1.03
Vested		(26,716	)	$	-
Forfeited		-		$	-
Nonvested as of September 30, 2023		709,560		$	1.15
Expected to vest		709,560

SCHEDULE OF SHARE BASED PAYMENT ARRANGEMENT

The table below summarizes total remaining stock-based compensation for all outstanding awards: 

Fiscal Period
Remainder of fiscal 2024	$	329,882
Fiscal 2025		474,180
Fiscal 2026		346,121
Fiscal 2027		176,233
Fiscal 2028		10,290
Total stock-based compensation	$	1,336,706